The Pharmaceutical Equipment Manufacturing Market was valued at USD 19.77 billion and is projected to reach a market size of USD 27.05 billion by the end of 2030. Over the forecast period of 2025-2030, the market is projected to grow at a CAGR of 6.47%.
The term "pharmaceutical manufacturing equipment" refers to a broad category of gear used in the pharmaceutical business to efficiently, safely, and securely package pharmaceutical products. The Pharmaceutical Equipment market is something that in recent years has seen decent amount of growth. This has been primarily attributable to the shifting population dynamics in Western countries as the population growth is stalling and the projected number of retirees in our forecast period will be increasing considerably. This has meant a requirement of more medication to treat chronic diseases and illnesses. This demand has translated to the pharmaceuticals equipment manufacturing sector as manufacturers want to increase production.
Key Market Insights:
Eli Lilly is investing an extra $3 billion to expand its manufacturing plant in Wisconsin's Kenosha County. The objective of this expansion is to increase the production of injectable medications, such as Zepbound and Mounjaro, which together brought in $4.4 billion in sales in the most recent quarter. 2025 is when construction is expected to start.
GSK has reported plans to double the size and capability of its production facility in Marietta, Pennsylvania and invest up to $800 million. Two more facilities will be added as part of the project to enhance the production of medications and existing drug product capabilities.
Various Innovations are also taking place in equipment design for mixing and blending machines to ensure consistency across pharma production. These machines are also designed to meet US FDA and CGNP requirements and regulatory standards.
Emerging markets (India, China, Brazil) are experiencing rapid pharmaceutical sector growth, driving investments in production infrastructure. India’s pharmaceutical industry alone is expected to reach $130 billion by 2030 (IBEF).
Pharmaceutical Equipment Manufacturing Market Drivers:
Aging Population poses a greater demand for pharmaceutical products.
The key reason this manufacturing market is seeing increasing demand is because of the western countries aging problem. The birth rate for major economies such as US, South Korea, EU etc. is going well below the replacement rate of 2.1. The older generation born during the boom years of the 50’s 60’s and the 70’s are now entering old age and in becoming prone to various diseases. In the US according to the CDC 7 out of 10 people suffer from some form of chronic illness and the number is projected to rise rapidly. By 2050, the global population aged 65 and older is expected to double, reaching 1.6 billion (UN). For accuracy and scalability, this expansion needs top-notch, automated manufacturing equipment. As a consequence, producers of pharmaceutical equipment are investing money on continuous manufacturing systems, AI, and sophisticated robotics.
Biopharmaceuticals, regulatory requirements are also adjusted to preserve efficiency and quality both.
Apart from an ageing population, there are other factors driving the market for pharmaceutical equipment manufacture. Demand for drugs is rising as a result of the increasing prevalence of chronic diseases, with the WHO projecting that there will be 28.4 million instances of cancer worldwide by 2040. The demand for advanced manufacturing systems is being driven by biopharmaceuticals, which include gene treatments and biologics. The market is expected to reach $749 billion by 2028. Manufacturers are pushed towards automation and precision by strict regulatory standards (FDA, EMA, cGMP). Efficiency and cost-effectiveness are being enhanced by advances in robots, artificial intelligence, and continuous manufacturing. Pharmaceutical manufacturing is increasing in emerging markets like India, which is expected to reach $130 billion by 2030. Additionally, investments in flexible, high-tech manufacturing processes are rising the pace of vaccine development and pandemic preparedness
Pharmaceutical Equipment Manufacturing Market Restraints and Challenges:
High Capital requirements in a volatile Interest rate environment have increased the risk associated with the market.
Companies which pursue pharma production or are looking to enter this market will require high capital investment as setting up manufacturing facilities is costly and while these costs were previously done in low-interest rate environments, that has changed since covid and the ensuing inflation, because of high interest rates the cost of capital across the globe has increased significantly making it difficult to enter this market. Existing players are also finding it difficult to secure funding and stick to development timelines. The initial capital investment is also increased because of stringent regulatory compliance requirements across different regions, necessitating substantial investments in quality control and documentation. Additionally, there is dependency on various companies across the globe for parts and other material which makes supply chain management very important.
Pharmaceutical Equipment Manufacturing Market opportunities:
The market for manufacturing pharmaceutical equipment has considerable potential for expansion due to shifting industry demands. Significant opportunities are presented by the increase in outsourcing and contract manufacturing, especially in developing nations where companies are searching for inexpensive production alternatives. There is an increasing demand for specific, high-precision technology due to the growth of personalised medicine and cell and gene therapies. Efficiency increases are achievable through automation and AI-driven production, which lowers expenses and enhances regulatory compliance.
PHARMACEUTICAL MANUFACTURING EQUIPMENT MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2024 - 2030 |
|
Base Year |
2024 |
|
Forecast Period |
2025 - 2030 |
|
CAGR |
6.47% |
|
Segments Covered |
By Product type, Equipment Type, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
GEA, SED Pharma, Syntegon Tech, IMA Group, GSK, Glatt, Eli Lily, Sartorius AG, ACG Worldwide, Paul Mueller Company |
Solid
Liquid
Semi-Solid
The Solid form i.e. tables, tablet pressers, powders hold the largest market share at 45%, the liquid dosage equipment such as injections etc. is seeing its share increasing significantly due to various innovations. Factors such as regulatory compliance combined with a need for cost effectiveness are fueling the rising demand in these segments.
The liquid dosage in particular has seen increase in demand as vaccine demands and various research being done to address other problems through this has meant that a good amount of capital investment has flowed to the companies which manufacture this sort of an equipment.
Processing Equipment
Packaging Equipment
The market to produce pharmaceutical equipment is divided into two sections: packaging equipment and processing equipment. Owing to the rise in the manufacture of biologics and generic medications, processing equipment—used for drug formulation, mixing, granulation, and sterilization—accounts for the greatest portion of the market, at over 60%. Led by the need for tamper-proof and intelligent packaging solutions, packaging equipment, which consists of blister packing, filling, and labelling machines, accounts for around 40% of the market with a compound annual growth rate (CAGR) of 7-8%. Investments in innovative pharmaceutical packaging technologies are being further stimulated by a rise in serialisation and track-and-trace requirements. Both sectors are changing to meet strict industry requirements while enhancing production efficiency as a consequence of automation and digitisation.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
The biggest demand for the equipment comes from US and the EU with it totaling at 40-50%. Asia Pacific occupied around 39% of the market and is expected to grow from 2025 and 2034 at a CAGR of about 7.1%. Cost advantages, high manufacturing capacity, and a highly skilled labour force are the main drivers of supremacy, with China and India making major contributions.
The primary driver for this demand from the West is the aging population and the primary driver for manufacturing in countries of Asia/Pacific region is the relatively cheaper labour. While the Africa and some Asian countries are still reproducing above the replacement rate of 2.1 other countries have an aging population catching up such as Japan, South Korea and even China. The demand from these countries is also expected to grow which has meant more investments in manufacturing.
COVID-19 Impact Analysis on the Pharmaceutical Equipment Manufacturing Market:
The COVID-19 pandemic initially disrupted the pharmaceutical equipment manufacturing market through supply chain challenges but quickly spurred unprecedented growth driven by urgent vaccine production needs. This led to surging demand for specialized equipment like bioreactors, filling lines, and cold storage systems. The pandemic accelerated key trends including automation, digitization, and investment in flexible manufacturing capabilities. Governments increased funding for pharmaceutical manufacturing infrastructure, while manufacturers focused on single-use technologies and modular equipment. The long-term impact includes sustained investment in manufacturing capabilities, faster adoption of Industry 4.0 technologies, and greater emphasis on continuous manufacturing processes and quality control systems.
Latest Trends/ Developments:
In Grangemouth, Scotland, Piramal Pharma Solutions built a brand-new, innovative Antibody-Drug Conjugate (ADC) manufacturing plant. The firm's ADC production capacity is increased by roughly 70–80% due to this £45 million investment, that meets the sector's rising demand.
AstraZeneca has cancelled its planned £450 million investment in a new vaccine manufacturing plant in Speke, Liverpool, after prolonged negotiations with the UK government. The decision has raised concerns about the UK's attractiveness for pharmaceutical investments.
India is often referred to as the pharmacy of the world and various companies have a broad range of drugs and other medicines which are manufactured here. In the recently announced Budget, FDI limit in greenfield pharma was increased to 100% under the automatic route.
Key Players:
GEA
SED Pharma
Syntegon Tech
IMA Group
GSK
Glatt
Eli Lily
Sartorius AG
ACG Worldwide
Paul Mueller Company
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The pharmaceutical equipment manufacturing market is projected to reach USD 27.05 billion by 2030, growing at a CAGR of 6.8% from its current value of USD 19.41 billion.
The solid form segment, which includes tablets, tablet pressers, and powders, holds the largest market share at 45%. However, the liquid dosage equipment segment is showing significant growth due to innovations and increasing vaccine demands.
The market is divided into two main segments: processing equipment and packaging equipment. Processing equipment, used for drug formulation, mixing, granulation, and sterilization, holds the larger share at over 60%. Packaging equipment accounts for around 40% of the market and is growing at a CAGR of 7-8%.
The US and EU combined account for 40-50% of the market demand, while the Asia Pacific region occupies around 39% of the market. The Asia Pacific region is expected to grow at a CAGR of about 7.1% from 2025 to 2034, driven by cost advantages, high manufacturing capacity, and skilled labour force, particularly in China and India.
The COVID-19 pandemic initially disrupted pharmaceutical equipment manufacturing but soon drove rapid growth due to urgent vaccine production. This spurred demand for specialized equipment and accelerated trends like automation, digitization, and flexible manufacturing
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
